Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome

ClinicalTrials.gov ID: NCT00269412

Public ClinicalTrials.gov record NCT00269412. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 31, 2026, 6:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess The Efficacy and Safety of Three Different Doses (275, 550 AND 1100 MG) of Rifaximin Administered BID For Either Two or Four Weeks in The Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is placebo-controlled study of three rifaximin doses in patients with DIBS. Subjects will be randomized to receive daily doses of placebo BID, rifaximin 275 mg BID, rifaximin 550 mg BID, or 1100 mg BID for 14 days. These four groups will subsequently receive an additional two weeks of placebo for a total of 4 weeks of treatment. A fifth group of subjects will receive rifaximin 550 mg BID for a period of 28 days. Subjects who successfully respond to treatment at the end of the 28-day Treatment Phase will be followed in a Post-treatment Phase that includes study visits during Weeks 6, 8, 12 and 16. Subjects who relapse during the Post-treatment Phase will be discontinued from the study.

Study identification

NCT ID
NCT00269412
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bausch Health Americas, Inc.
Industry
Enrollment
525 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2005 (Type not available)
Primary completion
Aug 2007 (Actual)
Completion
Sep 2008 (Actual)
Last update posted
Nov 25, 2019

2005 – 2008

United States locations

U.S. sites
67
U.S. states
26
U.S. cities
64
Facility City State ZIP Site status
Mayo Clinic Scottsdale Scottsdale Arizona 85259 —
Premeire Pharmaceutical Research Tempe Arizona 85282 —
Advanced Clinical Research Institute Anaheim California 92801 —
Lovelace Scientific Resources Irvine California 92618 —
West Gastroenterology Medical Group Los Angeles California 90045 —
Beverly Hills Gastroenterology Los Angeles California 90067 —
Medical Associates Research Group San Diego California 92123 —
Gastroenterology Associates of Fairfield County Bridgeport Connecticut 06606 —
Connecticut Gastroenterology Institute Bristol Connecticut 06010-0977 —
Litchfield County Gastroenterology Associates, LLC Torrington Connecticut 06790 —
Clinical Research of West Florida Clearwater Florida 33765 —
University Clinical Research DeLand Florida 32720 —
Research Consultants Group Hialeah Florida 33016 —
Borland-Groover Clinic Jacksonville Florida 32256 —
Miami Research Associates Miami Florida 33173 —
Advanced Gastroenterology Associates Palm Harbor Florida 34684 —
Shafran Gastroenterology Winter Park Florida 32789 —
Florida Medical Clinic Zephyrhills Florida 33542 —
Rockford Gastroenterology Rockford Illinois 61107 —
Community Clinical Research Center Anderson Indiana 46016 —
Indianapolis Gastroenterology Research Foundation Indianapolis Indiana 46237 —
Gastrointestinal Clinic of Quad Citites Davenport Iowa 52807 —
University of Kansas Medical Center Kansas City Kansas 66160-7350 —
Digestive Disorders Associates Annapolis Maryland 21401 —
Chevy Chase Clinical Research Chevy Chase Maryland 20815 —
Washington County Hospital Hagerstown Maryland 21740 —
Maryland Clinical Trials Severna Park Maryland 21146 —
Capital Gastroenterology Consultants, PA Silver Springs Maryland 20901 —
Coastal Research Associates Braintree Massachusetts 02184 —
Henry Ford Hospital Chesterfield Michigan 48047 —
Gastrointestinal Associates, PA Jackson Mississippi 39202 —
Digestive Health Specialists, PA Tupelo Mississippi 38801 —
Gastroenterology and Hepatology Kansas City Missouri 64131 —
Center for Digestive & Liver Diseases, Inc. Mexico Missouri 65265 —
Specialist in Gastroenterology St Louis Missouri 63141 —
Gastroenterology Specialities Lincoln Nebraska 68503 —
Long Island Clinical Research Great Neck New York 11021 —
New York Center for Clinical Research Lake Success New York 11042 —
Asheville Gastroenterology Associates Asheville North Carolina 28801 —
University of North Carolina Chapel Hill North Carolina 27579 —
Charlotte Gastroenterology & Hepatology Charlotte North Carolina 28207 —
Vital re:Search Greensboro North Carolina 27408 —
Carolina Research Greenville North Carolina 27834 —
Bethany Medical Center High Point North Carolina 27262 —
East Carolina Gastroenterology Jacksonville North Carolina 28546 —
Wake Research Associates Raleigh North Carolina 27612 —
Not listed Rocky Mount North Carolina 27804 —
Hanover Medical Specialists, PA Wilmington North Carolina 28401 —
Consultants for Clinical Research Cincinnati Ohio 45219 —
Digestive Health Network Cincinnati Ohio 45220 —
GI & Liver Diseases Consultants Dayton Ohio 45440 —
Wells Institute for Health Awareness Kettering Ohio 45429 —
Oklahoma Foundation for Digestive Research Oklahoma City Oklahoma 73104 —
Digestive Health Specialists, PA Oklahoma City Oklahoma 73112 —
West Hills Gastroenterology Associates, PC Portland Oregon 97225 —
Columbia Gastroenterology Associates Columbia South Carolina 29203 —
ClinSearch Chattanooga Tennessee 37404 —
Regional Research Institute Jackson Tennessee 38305 —
Holston Valley Physicians Kingsport Tennessee 37660 —
Austin Gastroenterology Austin Texas 78745 —
Advanced Research Institute Ogden Utah 84405 —
University of Utah School of Medicine Salt Lake City Utah 84132 —
Internal Medicine Associates Danville Virginia 24541 —
Northwest Gastroenterology Associates Bellevue Washington 98004 —
North Pacific Clinical Research Redmond Washington 98052 —
Spokane Digestive Disease Center Spokane Washington 99204 —
Wisconsin Center for Advanced Research Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00269412, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 25, 2019 · Synced Oct 31, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00269412 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →